In this article, the authors evaluated the practice trends and three-year outcomes following transcatheter edge-to-edge repair (TEER) and surgical repair for degenerative MR in the United States. Medicare and Medicaid data of 53,117 mitral valve interventions for degenerative MR (surgery or TEER) between 2012 and 2019 were analyzed.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mitral valve disease
January 24, 2024
January 23, 2024
In this video, we are excited to share our latest educational innovations, including the development of a tele-simulator and a tele-simulation curriculum for endoscopic mitral valve surgery.
January 18, 2024
In this series of videos, Dr. Vincent Gaudiani shares his experience in the new field of surgery after previous TAVR and provides his tips for safely performing redo surgery for a variety of indications including TAVR early and late failure, endocarditis, and when further valve surgery is required.
January 10, 2024
This is a report on the first dedicated minimally invasive right atrial retractor for tricuspid valve surgery.
January 4, 2024
The authors used machine learning techniques on twenty-year outcome data from 436 consecutive patients who underwent mitral valve repair over an eighteen-year period. The endpoints were actuarial survival and freedom from moderate or high mitral regurgitation (MR).
December 22, 2023
In this recording from the 2023 Transcatheter Heart Valves Greece conference, Dr. Stefan Anker, a cardiothoracic surgeon, professor, and researcher at Charite Medical School in Berlin, Germany, gave the meeting’s keynote lecture. He discussed an update in research for TEER for FMR in heart failure patients.
December 7, 2023
Minimally invasive mitral valve surgery (MIMVS) is feasible and safe, but its uptake has lagged worldwide. The authors conducted a detailed survey of 75 surgeons, of whom 32 (42 percent) completed the survey. All who completed the survey performed more than 25 MIMVS cases annually.
November 30, 2023
The use of bioprostheses for mitral valve replacement is well established and steadily increasing worldwide. However, long-term durability is not well described. Accurate mitral valve bioprosthetic durability reports are necessary to set a standard against which transcatheter mitral valve replacement can be compared.
November 9, 2023
Editor in chief Joel Dunning spoke with Dr. Peyman Sardari Nia during his port-access mitral valve repair training session at the 2023 EACTS annual meeting.
October 2, 2023
This video demonstrates minimally invasive mitral valve repair surgery performed successfully on a fifty-one-year-old man with mitral regurgitation secondary to a flail P2 segment.